article thumbnail

The Belgian Data Protection Authority Publishes Recommendation Concerning Data Processing for Direct Marketing Purposes

HL Chronicle of Data Protection

For example, a public administration targeting specific groups susceptible to specific diseases does not engage in direct marketing unless a specific medicinal product and/or pharmaceutical company is mentioned. Fulfilment of Transparency Obligations and making sure that Data Subjects can exercise their rights. How to Comply?

article thumbnail

Article 29 Working Party Releases Opinion on EU-U.S. Privacy Shield

Hunton Privacy

Privacy Shield (the “ Privacy Shield ”) draft adequacy decision. The Privacy Shield was created to replace the previous Safe Harbor framework invalidated by the Court of Justice of the European Union (“CJEU”) in the Schrems decision. Commercial Aspect of the Privacy Shield. Background. Purpose Limitation.

Privacy 49
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Good, Bad, And The Ugly: Key Takeaways From California’s New Privacy Law

Privacy and Cybersecurity Law

Consumer privacy rights in California are well established. The California Constitution expressly grants California citizens a right to privacy. The International Association of Privacy Professionals estimates at least 500,000 U.S. The ballot initiative largely mirrored what is now the language in the CCPA.

Privacy 58
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

This is the sixth installment in Hogan Lovells’ series on the California Consumer Privacy Act. The California Consumer Privacy Act of 2018 (CCPA) adds another set of privacy requirements for health and life sciences companies. Some considerations in making that assessment: Is the company a provider of health care?

Privacy 45
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

This is the sixth installment in Hogan Lovells’ series on the California Consumer Privacy Act. The California Consumer Privacy Act of 2018 (CCPA) adds another set of privacy requirements for health and life sciences companies. Some considerations in making that assessment: Is the company a provider of health care?

Privacy 40
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

This is the sixth installment in Hogan Lovells’ series on the California Consumer Privacy Act. The California Consumer Privacy Act of 2018 (CCPA) adds another set of privacy requirements for health and life sciences companies. Some considerations in making that assessment: Is the company a provider of health care?

Privacy 40
article thumbnail

CNIL Unveils 2017 Inspection Program and 2016 Annual Activity Report

Hunton Privacy

health and social sector issues such as difficulties accessing medical or social records, and the creation of pharmaceutical records without consent (3 percent of complaints). This legislation strengthens the transparency requirements and increases the maximum level of fines from €150,000 to €3 million for data protection infringements.